Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Medicinal plants have been used by mankind since ancient times, and many bioactive plant secondary metabolites are applied nowadays both directly as drugs, and as raw materials for semi-synthetic modifications. However, the structural complexity often thwarts cost-efficient chemical synthesis, and the usually low content in the native plant necessitates the processing of large amounts of field-cultivated raw material. The biotechnological manufacturing of such compounds offers a number of advantages like predictable, stable, and year-round sustainable production, scalability, and easier extraction and purification. Plant cell and tissue culture represents one possible alternative to the extraction of phytochemicals from plant material. Although a broad commercialization of such processes has not yet occurred, ongoing research indicates that plant in vitro systems such as cell suspension cultures, organ cultures, and transgenic hairy roots hold a promising potential as sources for bioactive compounds. Progress in the areas of biosynthetic pathway elucidation and genetic manipulation has expanded the possibilities to utilize plant metabolic engineering and heterologous production in microorganisms. This review aims to summarize recent advances in the in vitro production of high-value plant secondary metabolites of medicinal importance. Key points • Bioactive plant secondary metabolites are important for current and future use in medicine • In vitro production is a sustainable alternative to extraction from plants or costly chemical synthesis • Current research addresses plant cell and tissue culture, metabolic engineering, and heterologous production Graphical abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accelerating extinction risk from climate change
Urban, M. C. (2015) · Science · doi:10.1126/science.aaa4984 · Cited by 2,436
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Neag, M. A., Mocan, A., Echeverría, J., Pop, R. M., Bocsan, C. I., Crişan, G., & Buzoianu, A. D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00557 · Cited by 562
Chandran, H., Meena, M., Barupal, T., & Sharma, K. (2020) · Biotechnology Reports · doi:10.1016/j.btre.2020.e00450 · Cited by 462
Initiation, growth and cryopreservation of plant cell suspension cultures
Mustafa, N. R., de Winter, W., van Iren, F., & Verpoorte, R. (2011) · Nature Protocols · doi:10.1038/nprot.2010.144 · Cited by 235
Synthetic biology’s first malaria drug meets market resistance
Peplow, M. (2016) · Nature · doi:10.1038/530390a · Cited by 143 · cited 1×
“However, the process was not viable because of the then lower price of plant-derived drug in the fluctuating artemisinin market (Peplow 2016).”
BackgroundMajdi, C., Pereira, C., Dias, M. I., Calhelha, R. C., Alves, M. J., Rhourri-Frih, B., Charrouf, Z., Barros, L., Amaral, J. S., & Ferreira, I. C. F. R. (2020) · Antioxidants · doi:10.3390/antiox9050369 · Cited by 88
Zirpel, B., Stehle, F., & Kayser, O. (2015) · Biotechnology Letters · doi:10.1007/s10529-015-1853-x · Cited by 83
Wani, K. I., Choudhary, S., Zehra, A., Naeem, M., Weathers, P., & Aftab, T. (2021) · Planta · doi:10.1007/s00425-021-03676-3 · Cited by 74
Zebarjadi, A., Dianatkhah, S., Pour Mohammadi, P., & Qaderi, A. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2018.64.9.1 · Cited by 17
Cited by
Production of secondary metabolites using tissue culture-based biotechnological applications
Ozyigit, I. I., Dogan, I., Hocaoglu-Ozyigit, A., Yalcin, B., Erdogan, A., Yalcin, I. E., Cabi, E., & Kaya, Y. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1132555 · Cited by 261
Metadata
- Authors
- Wawrosch, C., & Zotchev, S. B.
- Venue
- Applied Microbiology and Biotechnology
- Published
- 2021-09
- Volume
- 105
- Issue
- 18
- Pages
- 6649-6668
- ISSN
- 0175-7598 (ISSN-L)
- 1432-0614
- OpenAlex
- W3197197775
- Cited by
- 246
- References
- 10
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook. https://app.cochat.ai/papers/10.1007/s00253-021-11539-w
- The paper
- Wawrosch, C., & Zotchev, S. B. (2021). Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-021-11539-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.